AKASA Brings Autonomous AI to Inpatient Coding and Clinical Documentation

AKASA on October 2, 2026 announced the launch of an autonomous AI platform for the mid-cycle of the healthcare revenue cycle, expanding the South San Francisco company from AI-powered prebill review into autonomous inpatient medical coding and clinical documentation integrity (CDI). AKASA, which describes itself as a leader in generative AI for the healthcare revenue cycle, said its customers represent more than $180 billion in aggregate net patient revenue and roughly 10% of U.S. inpatient discharges, approximately 1 in 10.

The company said inpatient volume processed through its AI products had grown almost 6x in the year preceding the launch, attributing the expansion of its health system customer base to those products. AKASA said it fine-tunes AI models for individual health systems, accounting for differences in patient populations, clinical criteria, documentation practices, and care complexity, an approach the company said supports complete documentation and accurate coding that better reflects the care delivered.

CEO and co-founder Malinka Walaliyadde cast the launch as an industry milestone. “For years, an autonomous mid-cycle has been a holy grail in our industry,” he said. “Today,…